News

News about our portfolio and KREAXI

Amolyt Pharma announces research collaboration with PeptiDream

Amolyt and Peptidream will collaborate to optimize and evaluate growth hormone receptor antagonists to select a candidate for clinical development as a potential treatment for acromegaly, a rare endocrine disorder. Complete press release Amolyt Pharma

Theranexus presents its latest scientific news

Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction between neurons and glial cells, is pleased to announce a research partnership with the University...